Brendan O'Grady

Brendan O'Grady is currently the Chief Executive Officer at Assertio, having previously held leadership roles at Glenmark Pharmaceuticals and Amwell. With extensive experience in the pharmaceutical industry, Brendan's career includes significant positions at Teva, where they served as President & CEO of Teva USA and Chief Commercial Officer for Global Specialty Medicines. Brendan's earlier roles included positions at Marion Merrell Dow and sanofi-aventis, showcasing a depth of expertise in sales and account management. Brendan holds a Bachelor of Science in Management Science with a marketing concentration from SUNY Geneseo and an MBA from Baker University.